NFE2L2 and metabolic dysfunction-associated steatotic liver disease: The current study indicated that fat-rich diet-induced NAFLD exhibited lower XIAP and Nrf2 activity levels, then mediated an increase in NLRP3 inflammasomes, resulting in hepatic inflammation and dyslipidemia.